Soluble ST2 dynamic changes predict the cardiorenal protective efficacy of arni in patients with heart failure with preserved ejection fraction: a meta-analysis
Background: Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of HF cases, predominantly affecting older adults with comorbidities such as hypertension, diabetes, and obesity. Despite the breakthrough provided by angiotensin receptor-neprilysin inhibitors (ARNI), approximately 30%...
Yong Il Ho, Zhi-Quan Wang, Jong-Suk Mun et al.
· Bulgarian Cardiology · 0 citations